drugset / Trial / NCT03010423

Efficacy Study of Oral Nicorandil on Improving Microvascular Function in Female Non-obstructive Coronary Artery Disease (CAD) Participants

NCT03010423 ↗

NaSingle-groupOpen-labelTreatment

Summary

The study is a single-center, interventional, pilot study to evaluate the improvement of microvascular function by positron emission tomography (PET) after twelve-week treatment of oral nicorandil in female non-obstructive CAD Participants.

Timeline

Start
2016-11-30
Primary completion
2019-07-09
Completion
2019-07-09

Outcome

Outcome not reported

Stopped: “The study was terminated early, due to the lack of approval of data exportation from the Office of Human Genetic Resource Administration (OHGRA) China.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicorandil Other / unclassified 5 mg Oral